WUHAN-GATES – 46. “SARS-COV-2 Designed Bioweapon. Toxic structure May be Replicated in Vaccines”. US Army Ret. Colonel said
On the cover Lawrence Sellin and the SARS-Cov-2 manmade in an affair between China and Us Central Intelligence Agency
Introduction by Gospa News
Lawrence Sellin, Ph.D. is a retired US Army Colonel, who previously worked at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and conducted basic and clinical research in the pharmaceutical industry. USAMRIID is the main American center for research on countermeasures to be adopted in the event of biological warfare. It is located in Fort Detrick, a military-medical facility in the state of Maryland.
Gospa News spoke about it on the occasion of the WuhanGates 7 investigation into all laboratories controlled by the Department of Defense (Pentagon) or the Department of Health and Human Services (HHS) thanks to the supervision of the director of the NIAID (National Institute of Allergies and Infectious Diseases), Anthony Fauci, White House consultant for the Covid emergency.
Sellin therefore has ultra-specific expertise in the field of biological weapons but was also a veteran of Afghanistan, Iraq and West Africa and trained in Arabic and Kurdish. He is a veteran of Afghanistan, Iraq and West Africa and trained in Arabic & Kurdish.
In a recente interview with Vivek Sinha published by New Intervention the veteran supported the theory of the origin of the laboratory virus as already highlighted by 45 Gospa News reportages entitled WuhanGates in which we have unveiled the affair between China and Us Central Intelligence Agency.
Below we reported an extract of this interview and then the Sellin’s post published by The Gateway Pundit. Inside the article there all the more important links to Gospa News investigations.
Lawrence Sellin said: The narrative that the COVID-19 pandemic was the result of a naturally-occurring disease outbreak was never a scientifically viable conclusion. The argument was that a precursor of SAR-CoV-2, the Coronavirus responsible for the COVID-19 pandemic, while circulating in a bat population, mutated, acquiring the ability to infect humans.
It was then transmitted to people either visiting or working in the Wuhan Seafood Market, perhaps through an intermediate animal host, like pangolins, the scaly anteater. It was, however, already known by the end of January 2020, that the initial patients hospitalized between December 1st to December 10th, 2019 had not visited the market and bats were not sold there. It has also been found that pangolins were not the intermediate host animals.
The theory that the Wuhan’s Huanan Seafood Wholesale Market was the first source for animal–human viral transmission is now totally discredited, even by the Chinese Centers for Disease Control and Prevention.
Furthermore, the structure of SAR-CoV-2 is different in some very significant ways from any of the close Coronavirus relatives so far identified. Much of the scientific inquiry related to the origin of SAR-CoV-2 has centered on a particular component of Coronavirus structure called the spike glycoprotein, which carries the ability for the virus to bind itself to a human cell and gain entry.
Although the scientific consensus says that SARS-CoV-2 came from bats, the binding component appears more closely related to pangolins, which likely explains the initial claim that pangolins acted as an intermediate host. There exists another structure in SARS-CoV-2 called a furin polybasic cleavage site that is not found in any of the closely related bat Coronaviruses.
The probability of those two structural components evolving together in nature is very low. In contrast, experiments artificially inserting such components into Coronaviruses have long been done by Chinese scientists.
Given the significant differences between the structure of SAR-CoV-2 and naturally-evolving bat Coronaviruses, the burden of proof is now on China to prove it was a natural outbreak.
by Gateway Pundit
A previous Gateway Pundit article identified two “smoking guns” supporting the conclusion that COVID-19 was created in a laboratory. First, a de facto scientific recipe for the laboratory creation of COVID-19 was described in the 2018 research grant application to the U.S. Department of Defense’s Defense Advanced Research Projects Agency (DARPA) submitted by scientists who directly collaborated with the “bat woman” Zheng-Li Shi of the Wuhan Institute of Virology.
The research proposal explicitly states that bat coronaviruses, collected in southern China by the Wuhan Institute of Virology, would be isolated and genetically sequenced, particularly the spike proteins, which are the binding elements initiating infection.
It was further proposed that spike proteins demonstrating “high risk” for human infection would be artificially combined with other bat coronavirus “backbones,” creating entirely new and potentially dangerous coronaviruses.
The second smoking gun in the DARPA grant application was the artificial insertion of furin polybasic cleavage sites, short sequences of amino acids e.g. proline-arginine-arginine-alanine or PRRA, long-known to increase infectivity and lethality of coronaviruses.
The PRRA sequence found in COVID-19, does not exist in any of hundreds of close bat coronaviruses relatives from which COVID-19 could have evolved. The 2018 DARPA research application proposed to artificially insert furin polybasic cleavage sites, like PRRA, into low-risk bat coronaviruses and then testing the ability of those laboratory-created viruses to infect human cells.
That application was ultimately rejected by DARPA because it involved dangerous “gain of function” experiments creating new human-infecting viruses, which also have the potential for dual use as bioweapons.
It is important to note that the section of the COVID-19 genetic code (CGG-CGG) that produces the “RR” segment of the PRRA sequence is extremely rare. The two tandem CGG codons do not appear anywhere else in the COVID-19 genetic code, nor does it exist in that context in any close bat coronavirus relative of COVID-19. Thus, CGG-CGG is a unique marker both as an indicator of its laboratory origin and its potential role as a designed feature of the disease process.
As a confirmation of those observations, the same authors demonstrated that monoclonal antibodies directed against Staphylococcal enterotoxin B “superantigen” inhibit the entry of the COVID-19 virus into cultured cells. It may be no accident that China’s People’s Liberation Army’s Third Military Medical University has done extensive research on SEB and “superantigens,” because that center has been implicated in the creation of COVID-19 and is associated with the recent monoclonal antibody “cure” announced for COVID-19.
Caution, therefore, is warranted regarding mandating COVID-19 mRNA vaccines, which initiate the synthesis of spike protein inside the human body and may replicate the toxic structures introduced into COVID-19, potentially becoming a causative factor in organ inflammation.
A scientific abstract published on November 8, 2021 concludes that the mRNA vaccines: “dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.”
Finally, it may be purely coincidental that Moderna, a biotechnology company that produces a COVID-19 mRNA vaccine, holds a patent (US 10,501,513 B2), filed on February 7, 2017, describing “protein cleavage” sites and including a complementary genetic sequence matching that for the furin polybasic cleavage site found in COVID-19.
Lawrence Sellin, Ph.D. is a retired US Army Colonel, who previously worked at the US Army Medical Research Institute of Infectious Diseases and conducted basic and clinical research in the pharmaceutical industry. He is a veteran of Afghanistan, Iraq and West Africa and trained in Arabic & Kurdish. His email address is firstname.lastname@example.org
Note: all links to Gospa News articles has been added by Gospa News editorial staff